All doses of tirzepatide and semaglutide increased the risk for gastrointestinal adverse events versus placebo, with tirzepatide 15 mg yielding the highest risk for nausea (risk ratio [RR], 3.57), vomiting (RR, 4.35), and diarrhea (RR, 2.04)
GLP-1 microdosing FAQs Does microdosing GLP-1 actually work
If you dont have insurance coverage for provider visits and lab visits, our clinic can help you understand the out-of-pocket costs before proceeding with the program
Tirzepatide typically produces greater weight loss in clinical trials than semaglutide, with patients losing 20-22% body weight versus 15-17% respectively
At this time, patients should not panic, but they should be informed
Choline is also a precursor of acetylcholine, a neurotransmitter vital to nerve and muscle function, and a component of lecithin, which is critical to normal liver metabolism